. Author manuscript; available in PMC: 2017 Nov 1.

Published in final edited form as: Dis Esophagus. 2016 Nov;29(8):906–912. doi: 10.1111/dote.12538

Table 4.

Data-driven anatomic and consensus neoadjuvant pathologic stage groups for adenocarcinoma

Analysis Group	ypT	ypN	ypM	Consensus Stage Group	pTNM Equivalent Group^a
1	T0	N0	M0	I	IIA
X	Tis	N0	M0	I	IIA
	T1	N0	M0	I	IIA
2	T2	N0	M0	I	IIA
3	T3	N0	M0	II	IIB
4	T0	N1	M0	IIIA	IIIA
X	Tis	N1	M0	IIIA	IIIA
	T1–2	N1	M0	IIIA	IIIA
	T4a	N0	M0	IIIB	IIIB
	T1	N2	M0	IIIB	IIIB
5 X	T0–1	N2	M0	IIIB	IIIB
	T2	N2	M0	IIIB	IIIB
	T3	N1–2	M0	IIIB	IIIB
	T4a	N1	M0	IVA	IVA
6 X	T4a	N2	M0	IVA	IVA
X	T4b	N0–2	M0	IVA	IVA
	Any	N3	M0	IVA	IVA
	Any	Any	M1	IVB	IVA

Note: X = not in data-driven analysis.

. Equivalent survival with pTNM consensus groups.